Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06633120 · ClinicalTrials.gov registry record · NA

In Vitro Maturation of Human Eggs

A NA study of Healthy and Infertility, sponsored by Colorado Center for Reproductive Medicine.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06633120: Recruiting NA study of Healthy and Infertility, sponsored by Colorado Center for Reproductive Medicine.

NCT06633120 is a NA study of Healthy and Infertility that is actively recruiting participants, run by Colorado Center for Reproductive Medicine. The registered enrollment target is 50 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06633120, a NA study of Healthy and Infertility, is actively recruiting participants, sponsored by Colorado Center for Reproductive Medicine.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication

Primary Outcome

Maturation rate of retrieved oocytes

Interventions

  • OTHER IVM

Study Locations (1)

Colorado

  • Colorado Center for Reproductive Medicine - Lone Tree

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-02-03
Est. Completion 2030-08-30
Phase NA

What NCT06633120 shows while recruiting

NCT06633120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower).

The record links to 10 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which IVM is the first listed.

NCT06633120 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06633120 about?

NCT06633120 is a clinical study titled "In Vitro Maturation of Human Eggs". CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for...

What is the current status of trial NCT06633120?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-02-03. Estimated completion is 2030-08-30.

What conditions does trial NCT06633120 study?

This clinical trial studies the following conditions: Healthy, Infertility, Infertility, Female, PCOS, PCOS (Polycystic Ovary Syndrome).

What interventions are being tested in trial NCT06633120?

The interventions under investigation include: IVM (OTHER).

Who is sponsoring clinical trial NCT06633120?

This trial is sponsored by Colorado Center for Reproductive Medicine, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06633120 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06633120's enrollment target sits among peer trials

50 448th of 1090 higher than 618 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

  • NCT01746836 · 50 participants · Phase 2

    Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06633120, the US trial registry maintained by the National Library of Medicine. NCT06633120 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.